Stress hormone cortisol to help overcome phobias

Mar 29, 2011 by Deborah Braconnier report

(PhysOrg.com) -- In a recent study published in the Proceedings of the National Academy of Sciences, researchers are showing the potential benefit of using the stress hormone Cortisol in addition to exposure therapy to help patients overcome phobias.

Current treatment utilizes what is known as exposure therapy. Patients are exposed to their fear in safe environments in the hopes to replace fearful memories.

Cortisol, a hormone which is released during , has also been shown to affect the learning process. The hope of the study is that, when used with current exposure therapy treatment, the Cortisol will help to generate new memories of the experience and block the memories of being frightened.

Led by cognitive neuroscientist Dr. Dominique de Quervain from the University of Basel in Switzerland, researchers worked with participants suffering from acrophobia, or the fear of heights.

The researchers tested 40 patients with a fear of heights. The patients were put through three sessions of in a virtual-reality based format. The particular situation used was that of an outdoor elevator ride. Half of the participants were given a Cortisol tablet one hour before their session while the other half received a placebo.

Participants were questioned and measurements of the electrical conductance of their skin were taken at four days and once month after the final session. Researchers found that those participants who had been administered the Cortisol saw a much greater decrease in fear and anxiety when exposed to heights.

The level of fear showed an average drop of 60 percent in those administered the , compared to only a 40 percent drop with those receiving the placebo.

Further studies are going to be required and this is just the beginning. De Quervain hopes that eventually this combination of psychotherapy and pharmacotherapy can be used to treat more phobias such as post-traumatic stress disorder (PTSD), social phobias, and obsessive-compulsive disorder.

Explore further: Study finds potential genetic link between epilepsy and neurodegenerative disorders

More information: by Dominique J.-F. de Quervain, Glucocorticoids enhance extinction-based psychotherapy, Proceedings of the National Academy of Sciences, Published online before print March 28, 2011, doi: 10.1073/pnas.1018214108

Related Stories

Protected fear memories

Sep 11, 2009

(PhysOrg.com) -- In the latest issue of Science, researchers from the Friedrich Miescher Institute for Biomedical Research, Switzerland, show how a class of proteins surrounding nerve cells allows fear memories to persis ...

Easing the stress of trauma

Dec 01, 2008

Post-traumatic stress disorder (PTSD) affects as many as one in five of all Americans who survive a harrowing experience like rape, assault, war or terrorism. It has emotionally paralyzed survivors of 9/11 and broken up survivors' ...

Recommended for you

Study links enzyme to autistic behaviors

12 hours ago

Fragile X syndrome (FXS) is a genetic disorder that causes obsessive-compulsive and repetitive behaviors, and other behaviors on the autistic spectrum, as well as cognitive deficits. It is the most common ...

A new cause of mental disease?

18 hours ago

Astrocytes, the cells that make the background of the brain and support neurons, might be behind mental disorders such as depression and schizophrenia, according to new research by a Portuguese team from ...

Molecular basis of age-related memory loss explained

Jul 22, 2014

From telephone numbers to foreign vocabulary, our brains hold a seemingly endless supply of information. However, as we are getting older, our ability to learn and remember new things declines. A team of ...

The neurochemistry of addiction

Jul 22, 2014

We've all heard the term "addictive personality," and many of us know individuals who are consistently more likely to take the extra drink or pill that puts them over the edge. But the specific balance of ...

User comments : 0